View in EDS HTML Full Text PDF Full Text

Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma.

Saved in:
Bibliographic Details
Title: Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma.
Authors: Pucci P; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK., Lee LC; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK.; Merck & Co, 2000 Galloping Hill Rd, Kenilworth, NJ, 07033, USA., Han M; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK.; OncoSec, San Diego, CA, 92121, USA., Matthews JD; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK., Jahangiri L; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK.; Department of Life Sciences, Birmingham City University, Birmingham, UK.; Nottingham Trent University, School of Science & Technology, Clifton Lane, Nottingham, NG11 8NS, UK., Schlederer M; Department of Pathology, Division of Experimental and Translational Pathology, Medical University of Vienna, 1090, Vienna, Austria., Manners E; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK.; Chelsea and Westminster Hospital, NHS Foundation Trust, London, SW10 9NH, UK., Sorby-Adams A; MRC Mitochondrial Biology Unit, University of Cambridge, The Keith Peters Building, Cambridge Biomedical Campus, Hills Road, Cambridge, CB2 0XY, UK.; Department of Medicine, University of Cambridge, Addenbrookes Hospital, Hills Road, Cambridge, CB2 0QQ, UK., Kaggie J; Department of Radiology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK., Trigg RM; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK.; Functional Genomics, GlaxoSmithKline, Stevenage, SG1 2NY, UK., Steel C; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK., Hare L; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK.; Department of Paediatric Haematology, Oncology and Palliative Care, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK., James ER; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK., Prokoph N; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK., Ducray SP; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK., Merkel O; Department of Pathology, Medical University of Vienna, Vienna, 1090, Austria.; European Research Initiative for ALK related malignancies (ERIA), Cambridge, CB2 0QQ, UK., Rifatbegovic F; St. Anna Children's Cancer Research Institute, CCRI, Zimmermannplatz 10, 1090, Vienna, Austria., Luo J; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20814, USA., Taschner-Mandl S; St. Anna Children's Cancer Research Institute, CCRI, Zimmermannplatz 10, 1090, Vienna, Austria., Kenner L; Department of Pathology, Medical University of Vienna, Vienna, 1090, Austria.; European Research Initiative for ALK related malignancies (ERIA), Cambridge, CB2 0QQ, UK.; Unit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Vienna, Austria.; Center for Biomarker Research in Medicine (CBmed), Graz, Austria.; Christian Doppler Laboratory for Applied Metabolomics (CDL-AM), Medical University of Vienna, Vienna, Austria., Burke GAA; Department of Paediatric Haematology, Oncology and Palliative Care, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK., Turner SD; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK. sdt36@cam.ac.uk.; European Research Initiative for ALK related malignancies (ERIA), Cambridge, CB2 0QQ, UK. sdt36@cam.ac.uk.; Faculty of Medicine, Masaryk University, Brno, Czech Republic. sdt36@cam.ac.uk.
Source: Nature communications [Nat Commun] 2024 Apr 23; Vol. 15 (1), pp. 3422. Date of Electronic Publication: 2024 Apr 23.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38653965
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pucci+P%22">Pucci P</searchLink>; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK.<br /><searchLink fieldCode="AU" term="%22Lee+LC%22">Lee LC</searchLink>; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK.; Merck & Co, 2000 Galloping Hill Rd, Kenilworth, NJ, 07033, USA.<br /><searchLink fieldCode="AU" term="%22Han+M%22">Han M</searchLink>; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK.; OncoSec, San Diego, CA, 92121, USA.<br /><searchLink fieldCode="AU" term="%22Matthews+JD%22">Matthews JD</searchLink>; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK.<br /><searchLink fieldCode="AU" term="%22Jahangiri+L%22">Jahangiri L</searchLink>; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK.; Department of Life Sciences, Birmingham City University, Birmingham, UK.; Nottingham Trent University, School of Science & Technology, Clifton Lane, Nottingham, NG11 8NS, UK.<br /><searchLink fieldCode="AU" term="%22Schlederer+M%22">Schlederer M</searchLink>; Department of Pathology, Division of Experimental and Translational Pathology, Medical University of Vienna, 1090, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Manners+E%22">Manners E</searchLink>; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK.; Chelsea and Westminster Hospital, NHS Foundation Trust, London, SW10 9NH, UK.<br /><searchLink fieldCode="AU" term="%22Sorby-Adams+A%22">Sorby-Adams A</searchLink>; MRC Mitochondrial Biology Unit, University of Cambridge, The Keith Peters Building, Cambridge Biomedical Campus, Hills Road, Cambridge, CB2 0XY, UK.; Department of Medicine, University of Cambridge, Addenbrookes Hospital, Hills Road, Cambridge, CB2 0QQ, UK.<br /><searchLink fieldCode="AU" term="%22Kaggie+J%22">Kaggie J</searchLink>; Department of Radiology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.<br /><searchLink fieldCode="AU" term="%22Trigg+RM%22">Trigg RM</searchLink>; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK.; Functional Genomics, GlaxoSmithKline, Stevenage, SG1 2NY, UK.<br /><searchLink fieldCode="AU" term="%22Steel+C%22">Steel C</searchLink>; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK.<br /><searchLink fieldCode="AU" term="%22Hare+L%22">Hare L</searchLink>; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK.; Department of Paediatric Haematology, Oncology and Palliative Care, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.<br /><searchLink fieldCode="AU" term="%22James+ER%22">James ER</searchLink>; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK.<br /><searchLink fieldCode="AU" term="%22Prokoph+N%22">Prokoph N</searchLink>; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK.<br /><searchLink fieldCode="AU" term="%22Ducray+SP%22">Ducray SP</searchLink>; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK.<br /><searchLink fieldCode="AU" term="%22Merkel+O%22">Merkel O</searchLink>; Department of Pathology, Medical University of Vienna, Vienna, 1090, Austria.; European Research Initiative for ALK related malignancies (ERIA), Cambridge, CB2 0QQ, UK.<br /><searchLink fieldCode="AU" term="%22Rifatbegovic+F%22">Rifatbegovic F</searchLink>; St. Anna Children's Cancer Research Institute, CCRI, Zimmermannplatz 10, 1090, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Luo+J%22">Luo J</searchLink>; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20814, USA.<br /><searchLink fieldCode="AU" term="%22Taschner-Mandl+S%22">Taschner-Mandl S</searchLink>; St. Anna Children's Cancer Research Institute, CCRI, Zimmermannplatz 10, 1090, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Kenner+L%22">Kenner L</searchLink>; Department of Pathology, Medical University of Vienna, Vienna, 1090, Austria.; European Research Initiative for ALK related malignancies (ERIA), Cambridge, CB2 0QQ, UK.; Unit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Vienna, Austria.; Center for Biomarker Research in Medicine (CBmed), Graz, Austria.; Christian Doppler Laboratory for Applied Metabolomics (CDL-AM), Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Burke+GAA%22">Burke GAA</searchLink>; Department of Paediatric Haematology, Oncology and Palliative Care, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.<br /><searchLink fieldCode="AU" term="%22Turner+SD%22">Turner SD</searchLink>; Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, CB20QQ, UK. sdt36@cam.ac.uk.; European Research Initiative for ALK related malignancies (ERIA), Cambridge, CB2 0QQ, UK. sdt36@cam.ac.uk.; Faculty of Medicine, Masaryk University, Brno, Czech Republic. sdt36@cam.ac.uk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2024 Apr 23; Vol. 15 (1), pp. 3422. <i>Date of Electronic Publication: </i>2024 Apr 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38653965
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-024-47771-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3422
    Titles:
      – TitleFull: Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pucci P
      – PersonEntity:
          Name:
            NameFull: Lee LC
      – PersonEntity:
          Name:
            NameFull: Han M
      – PersonEntity:
          Name:
            NameFull: Matthews JD
      – PersonEntity:
          Name:
            NameFull: Jahangiri L
      – PersonEntity:
          Name:
            NameFull: Schlederer M
      – PersonEntity:
          Name:
            NameFull: Manners E
      – PersonEntity:
          Name:
            NameFull: Sorby-Adams A
      – PersonEntity:
          Name:
            NameFull: Kaggie J
      – PersonEntity:
          Name:
            NameFull: Trigg RM
      – PersonEntity:
          Name:
            NameFull: Steel C
      – PersonEntity:
          Name:
            NameFull: Hare L
      – PersonEntity:
          Name:
            NameFull: James ER
      – PersonEntity:
          Name:
            NameFull: Prokoph N
      – PersonEntity:
          Name:
            NameFull: Ducray SP
      – PersonEntity:
          Name:
            NameFull: Merkel O
      – PersonEntity:
          Name:
            NameFull: Rifatbegovic F
      – PersonEntity:
          Name:
            NameFull: Luo J
      – PersonEntity:
          Name:
            NameFull: Taschner-Mandl S
      – PersonEntity:
          Name:
            NameFull: Kenner L
      – PersonEntity:
          Name:
            NameFull: Burke GAA
      – PersonEntity:
          Name:
            NameFull: Turner SD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 04
              Text: 2024 Apr 23
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1